股票代码：002734 股票简称：利民股份 公告编号：2026-003 利民控股集团股份有限公司 关于"利民转债"摘牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 债券代码：128144 债券简称：利民转债 特别提示： 1、赎回日：2025 年 12 月 26 日 2、赎回款到达"利民转债"持有人资金账户日：2026 年 1 月 6 日 3、摘牌日：2026 年 1 月 7 日 4、摘牌原因：存续期内可转债触及有条件赎回条款全部赎回 一、可转换公司债券发行上市基本情况 （一）可转债发行情况 经中国证券监督管理委员会《关于核准利民控股集团股份有限公司公开发行可 转换公司债券的批复》（证监许可［2020］3390 号）的核准，公司向社会公开发行 面值总额为人民币 980,000,000.00 元的可转换公司债券，发行数量为 9,800,000 张， 每张面值为人民币 100 元，债券期限为 6 年。 （二）可转债上市情况 经深交所深证上【2021】278 号文同意，公司 980,000,000.00 元可转换公司债 券于 2021 年 3 月 24 日起 ...

| 股票代码：002734 | 股票简称：利民股份 | 公告编号：2026-001 | | --- | --- | --- | | 债券代码：128144 | 债券简称：利民转债 | | 利民控股集团股份有限公司 关于 2025 年第四季度可转债转股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 经深交所深证上【2021】278 号文同意，公司 980,000,000.00 元可转换公司债 券于 2021 年 3 月 24 日起在深交所挂牌交易，债券简称"利民转债"，债券代码 "128144"。 根据《利民控股集团股份有限公司公开发行可转换公司债券募集说明书》（以 下简称"《募集说明书》"）相关约定，本次发行的可转债转股期限自可转债发行结 束之日（2021 年 3 月 5 日）满六个月后的第一个交易日（2021 年 9 月 6 日）起至 可转债到期日（2027 年 2 月 28 日）止（如遇法定节假日或休息日延至其后的第 1 1 个工作日；顺延期间付息款项不另计息）。 | 证券代码：002734 | | 证券简称：利民股份 | | -- ...

Core Insights - Synthetic biology is leading a transformative change in the agricultural input industry, moving from a traditional reliance on natural processes to a model focused on design and creation [1][17] - Recognized as the "third biotechnology revolution," synthetic biology fundamentally shifts from interpreting natural laws to designing biological functions, impacting various sectors including health, environment, and energy [2][18] - The market acceptance of synthetic biology products is increasing as technology matures, with applications like polyglutamic acid proving their practical value in agriculture [3][19] Industry Transformation - Synthetic biology is reshaping the agricultural input industry by integrating multiple disciplines such as biology, engineering, and information technology, leading to innovations in product development and market ecology [1][17] - The industry is transitioning from traditional chemical-based methods to sustainable biological solutions, enhancing efficiency and reducing environmental impact [29][30] Product Development - A product system centered on functional microbial products and microbial secretions has emerged, including biofertilizers, biostimulants, and biocontrol products [22][23] - Companies are developing high-value microbial products through genetic engineering, which enhances agricultural functions and improves soil health [24][25] Market Trends - The demand for high-efficiency, green products in modern agriculture is driving the growth of synthetic biology applications, with significant market potential anticipated [3][19] - Companies like Limin Holdings are focusing on biomanufacturing, predicting that 60% to 70% of chemical products will be produced through biological synthesis in the future [5][21] Innovations in Crop Breeding - Synthetic biology enables the internal enhancement of crops, allowing for the development of varieties rich in specific nutrients and with greater resistance to stress [11][27] - This approach complements external agricultural inputs, creating comprehensive solutions for crop improvement and sustainability [12][28] Challenges and Future Directions - Despite the promising outlook, the industry faces challenges such as high technical barriers and the need for collaborative innovation to overcome production bottlenecks [15][31] - Companies are encouraged to promote awareness and understanding of synthetic biology products to expand their application in agriculture and enhance overall industry value [15][31]

Group 1 - Longbai Group's subsidiary plans to introduce strategic investors and implement capital increase, with a total investment of 2 billion yuan, resulting in a 31.40% equity stake for the investors [1] - Upwind New Materials' embodied intelligent robot business is still in the product development stage and is not expected to positively impact the 2025 annual performance [2] - Kweichow Moutai's controlling shareholder has completed a share buyback plan, acquiring approximately 207.14 million shares for about 3 billion yuan, increasing their total stake to 56.63% [3] Group 2 - Xiamen Tungsten's subsidiary plans to acquire 100% equity of German Mimatic Tool Company for a base price of 10 million euros, with additional capital increase planned [4] - Longpan Technology's subsidiary will reduce production on some lithium iron phosphate production lines for maintenance, expecting a reduction of about 5,000 tons [5] - Wenkai Co. plans to invest 29 million yuan to establish a fund focused on strategic emerging industries [6] Group 3 - Limin Co.'s subsidiary has received a production license for "fluopyram" pesticide, which is expected to have a positive impact on future operations [7] - ST Huicheng received a cash donation of 30 million yuan from its restructuring investor to support its operations [8] - Baitong Energy's vice president plans to reduce holdings of up to 316,200 shares, representing 0.0686% of the total share capital [9] Group 4 - Wushang Group's shareholder did not execute a planned share reduction, retaining a 5.7% stake [10] - Zhangzidao's major shareholder plans to reduce holdings of up to 711,100 shares, representing 1% of the total share capital [11] - Meihua Bio plans to repurchase shares worth 35 million to 50 million yuan at a price not exceeding 15 yuan per share [12] Group 5 - Xiyang Co. plans to distribute a cash dividend of 1.10 yuan per 10 shares, totaling 181 million yuan, which is 10.37% of the net profit for the first three quarters of 2025 [13] - Weike Technology plans to distribute a cash dividend of 6 yuan per 10 shares, totaling approximately 75.15 million yuan [14] - Guoyuan Securities plans to transfer 24.33% of Anyuan Fund's equity for 813 million yuan [15] Group 6 - Three Gorges Tourism's subsidiary plans to purchase part of the property for the Three Gorges Cruise Center for 136 million yuan [16] - Wukuang Development plans to acquire equity in Wukuang Mining and Luzhong Mining, with stock suspension announced [17][18] - Sijia Technology plans to invest 275 million yuan to acquire 20% equity in Guangcai Xincheng [19] Group 7 - Changan Automobile plans to raise no more than 6 billion yuan through a private placement for new energy vehicle projects [20] - Shenjian Co. reported that its aerospace business revenue is relatively small, accounting for only 0.20% of total revenue [21] - Zhiyuan New Energy's controlling shareholder plans to reduce holdings of up to 1.53% of the company's shares [22] Group 8 - Beimo High-tech plans to raise no more than 1.97 billion yuan through a private placement for various projects [23] - Hongri Pharmaceutical's injectable thymosin has passed the consistency evaluation for generic drugs [24] - Ningbo Fangzheng plans to acquire 20% equity in Anhui Fangzheng for 63.8 million yuan [25] Group 9 - Spring Airlines signed a purchase agreement for 30 Airbus A320neo aircraft, with a total price not exceeding 4.128 billion USD [26][27] - Oulu Tong's controlling shareholder plans to reduce holdings of up to 1.91% of the company's shares [28] - Tongli Technology plans to invest 86.7 million yuan to increase capital in Zhuerkang Technology [29] Group 10 - Ganfeng Lithium received a notice of prosecution for suspected insider trading, but operations remain normal [30] - ST Dongyi completed its capital increase plan and will resume trading [31] - Tianpu Co. clarified that it has no plans to engage in artificial intelligence-related business [32] Group 11 - ST Meigu's restructuring plan has been completed, and it will apply to lift the delisting risk warning [33] - Unigroup Guowei is planning to acquire controlling or full equity of Ruineng Semiconductor, with stock suspension announced [34] - Shengtong Energy's stock has been suspended for investigation due to significant price fluctuations [35][36] Group 12 - ST Sansheng applied to lift the delisting risk warning after completing its restructuring plan [37] - Yuekang Pharmaceutical submitted an application for H-share listing on the Hong Kong Stock Exchange [38] - Miaokelando's controlling shareholder plans to increase holdings of 2.55 million to 5.10 million shares [39] Group 13 - SMIC plans to acquire 49% equity in SMIC North for 40.601 billion yuan, aiming to enhance asset quality and business synergy [40]

Group 1 - The core viewpoint of the report indicates that Brent crude oil prices are expected to stabilize around $65 per barrel by the end of 2025, with current prices showing slight increases of 0.28% for Brent and 0.39% for WTI compared to the previous week [1][3] - The report highlights significant price increases in battery-grade lithium carbonate (up 10.79%) and industrial-grade lithium carbonate (up 10.78%), while sulfur and liquid chlorine experienced notable declines of -6.33% and -5.86% respectively [2][4] - The chemical industry is currently facing a weak performance overall, influenced by past capacity expansions and weak demand, although some sub-sectors like lubricants are performing better than expected [4] Group 2 - Investment opportunities are suggested in sectors such as glyphosate, chemical fertilizers, and high-dividend assets, with specific recommendations for companies like Jiangshan Chemical, Xingfa Group, and Yangnong Chemical [4] - The report emphasizes the importance of domestic demand and the potential impact of export uncertainties on the chemical industry, particularly in nitrogen and phosphate fertilizers which have relatively inelastic demand [4] - The report recommends focusing on companies with high asset quality and dividend yields, particularly Sinopec, which stands to benefit from lower raw material costs due to declining oil prices [4]

Investment Rating - The report maintains a "Buy" rating for several companies including Xinyangfeng, Senqilin, Ruifeng New Materials, Sinopec, Juhua, Yangnong Chemical, CNOOC, Tongkun, Daotong Technology, and others [10]. Core Viewpoints - The report highlights significant price increases in battery-grade lithium carbonate (up 10.79%) and industrial-grade lithium carbonate (up 10.78%), while sulfur and liquid chlorine experienced notable declines [4][7]. - It suggests focusing on investment opportunities in areas such as import substitution, pure domestic demand, and high dividend stocks, particularly in light of the current geopolitical tensions affecting oil prices [6][18]. - The overall chemical industry remains under pressure, with mixed performance across sub-sectors due to past capacity expansions and weak demand, although some sectors like lubricants are performing better than expected [21]. Summary by Sections Chemical Industry Investment Suggestions - The report recommends paying attention to the glyphosate industry, which is showing signs of recovery with decreasing inventory and rising prices, suggesting potential investment in companies like Jiangshan Co., Xingfa Group, and Yangnong Chemical [21]. - It also emphasizes selecting stocks with strong competitive positions and growth potential, particularly in the lubricant additive sector and coal-to-olefins industry [21]. - The report notes that domestic demand for chemical fertilizers and certain pesticide sub-products remains robust, with companies like Hualu Hengsheng and China Heartlink Fertilizer being highlighted for investment [21]. Price Trends of Chemical Products - The report details recent price movements, with significant increases in battery-grade lithium carbonate and PTA, while products like sulfur and liquid chlorine saw declines [4][5][19]. - It mentions that the international oil price is expected to stabilize around $65 per barrel, which could benefit companies with high dividend yields and those that are sensitive to raw material cost reductions [6][18]. Market Dynamics - The report discusses the impact of geopolitical tensions on oil prices, particularly the situation in Venezuela and the EU's sanctions on Russia, which have contributed to recent price fluctuations [22][23]. - It highlights the weak trading atmosphere in the coal market, with prices declining due to limited demand and cautious market sentiment [29][30]. - The report notes that the polypropylene market is experiencing downward pressure due to weak demand and increased supply, while the PTA market is expected to remain strong due to ongoing inventory reduction [31][35].

Group 1 - The core point of the news is that several companies are making significant announcements regarding their business operations, including product development, investments, and acquisitions [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] Group 2 - Company Upwind New Materials is still in the product development stage for its embodied intelligent robot business and has not achieved mass production or large-scale sales, which is expected to have no positive impact on its 2025 performance [2] - Longpan Technology's subsidiary will reduce production of lithium iron phosphate by approximately 5,000 tons due to maintenance, which is not expected to significantly impact the company's 2026 performance [8] - Spring Airlines plans to purchase 30 Airbus A320neo aircraft, with a total transaction value not exceeding $4.128 billion [17] - Longbai Group's subsidiary will introduce strategic investors and implement a capital increase of 2 billion yuan, primarily to repay bank loans [2] - Xiamen Tungsten's subsidiary plans to acquire 100% of German Mimatic Tool Company for a base price of 10 million euros [3] - Huahan Co. will invest 68.25 million yuan to establish a private equity fund focused on commercial aerospace [4] - Limin Co. has received a production license for "Fluopyram" from Jiangsu Province, which is expected to positively impact future operations [5] - Yinlun Co. plans to increase capital in its subsidiaries for the construction of production bases in Mexico and Sichuan [6] - New Jinlu's subsidiary plans to invest in mining and smelting projects with an estimated total investment of 496 million yuan [8] - Guiguan Electric Power intends to acquire 100% of Datang Tibet Energy Development Co. and China Datang Group ZDN Clean Energy Development Co. for 2.025 billion yuan [8] - Macro Micro Technology has signed a strategic cooperation agreement with a leading domestic company to jointly research GaN power semiconductor devices [9] - Tianqi Co. plans to raise up to 977 million yuan for the development of intelligent systems for the automotive industry [9] - Nanchin Technology intends to sign an agreement with a related party for the development of IP [9] - New Phoenix Ming plans to participate in the auction for a 35% stake in the Dushan Port Development Company for a base price of 259 million yuan [10] - Yonghui Supermarket plans to publicly transfer 28.095% of its stake in Yonghui Yunjin Technology [11] - Financial Securities has received approval from the CSRC to publicly issue bonds totaling up to 15 billion yuan [12] - Guangdong Yuedian's Dapu Power Plant Phase II project has been put into commercial operation with a total investment of 8.122 billion yuan [12] - Huaxin Environmental Protection's subsidiary plans to invest in a bonded remanufacturing project in Hainan with an estimated total investment of 350 million yuan [13] - Baodi Mining intends to purchase 87% of Congling Energy for 685 million yuan [13] - Tianjian Technology has signed a price adjustment agreement for military products, expecting a negative impact on net profit of approximately 209 million yuan [14] - Acolyte has successfully validated and begun bulk supply of a new product for the optical lens field [14] - Huayi Co. has terminated the acquisition of 51% of Zhongke Huilian due to a lack of consensus on key terms [15][16] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Qianxing Future to strengthen collaboration in the field of embodied intelligent robots [17] - Tianpu Co. has clarified that it has no plans to engage in AI-related business [17] - Chang'an Automobile plans to raise up to 6 billion yuan for the development of new energy vehicles and smart platforms [20] - Sijia Technology intends to acquire 20% of Guangcai Xincheng for 275 million yuan [21][22] - Wukuang Development plans to purchase shares of Wukuang Mining and Luzhong Mining, with its stock suspended from trading [22] - Guizhou Moutai's major shareholder has completed its shareholding increase plan, acquiring approximately 2.0714 million shares [23] - ST Dongtong's stock will resume trading and enter a delisting period [24] - ST Dongyi has completed the capital increase and will resume trading [25]

股票代码：002734 股票简称：利民股份 公告编号：2025-114 利民控股集团股份有限公司 生产地址：江苏省新沂经济开发区 生产范围：嘧霉胺、丙森锌、霜脲氰、硝磺草酮、代森锰锌、丙环唑、百菌 清、噻虫啉、苯醚甲环唑、三乙膦酸铝、嘧菌酯、代森锌、环磺酮(2024-03-14)、 氟吡菌酰胺(2025-12-25),悬浮剂、水分散粒剂、乳油、可湿性粉剂、可溶粉剂、 威百亩水剂(2021-02-02)、水剂、威百亩可溶液剂(2023-06-25)。 首次批准日期：2017 年 12 月 14 日 有效期至：2027 年 12 月 13 日 二、对上市公司的影响及风险提示 本次对于《农药生产许可证》的变更主要为生产范围的信息变更，增加了"氟 吡菌酰胺"的生产许可。此次变更有利于公司丰富产品组合，更好地满足市场需 求，进一步增强公司的核心竞争力。上述农药生产许可证生产范围变更对公司未 来生产经营将产生积极影响，预计对公司本年业绩无重大影响，敬请投资者注意 关于子公司农药生产许可证变更的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 利民控股集团股份有限公司（ ...

债券代码：128144 债券简称：利民转债 股票代码：002734 股票简称：利民股份 公告编号：2025-113 利民控股集团股份有限公司 关于"利民转债"即将停止转股 暨赎回前最后一个交易日的重要提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 1．最后转股日：2025 年 12 月 25 日 2025 年 12 月 25 日是"利民转债"最后一个转股日。当日收市前，持有"利 民转债"的投资者仍可进行转股；2025 年 12 月 25 日收市后，未转股的"利民转 债"将停止转股。 3．截至 2025 年 12 月 24 日收市后，距离"利民转债"停止转股并赎回仅剩 1 个交易日。本公司特别提醒"利民转债"持有人务必认真阅读本公告，充分了 解相关风险，注意最后转股时间，审慎作出投资决策。 特别提示： 1．赎回价格：101.22 元/张（含当期应计利息，当期年利率为 1.50%，且当 期利息含税），扣税后的赎回价格以中国证券登记结算有限责任公司深圳分公司 （以下简称"中登公司"）核准的价格为准。 2.赎回条件满足日：2025 年 12 ...

债券代码：128144 债券简称：利民转债 股票代码：002734 股票简称：利民股份 公告编号：2025-112 利民控股集团股份有限公司 关于提前赎回"利民转债"实施 暨即将停止转股的重要提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 1．最后转股日：2025 年 12 月 25 日 2025 年 12 月 25 日是"利民转债"最后一个转股日。当日收市前，持有"利 民转债"的投资者仍可进行转股；2025 年 12 月 25 日收市后，未转股的"利民转 债"将停止转股。 3．截至 2025 年 12 月 23 日收市后，距离"利民转债"停止转股并赎回仅剩 2 个交易日。本公司特别提醒"利民转债"持有人务必认真阅读本公告，充分了 解相关风险，注意最后转股时间，审慎作出投资决策。 特别提示： 1．赎回价格：101.22 元/张（含当期应计利息，当期年利率为 1.50%，且当 期利息含税），扣税后的赎回价格以中国证券登记结算有限责任公司深圳分公司 （以下简称"中登公司"）核准的价格为准。 2.赎回条件满足日：2025 年 12 月 4 ...